2013
DOI: 10.1074/jbc.m112.445437
|View full text |Cite
|
Sign up to set email alerts
|

Engineering Visual Arrestin-1 with Special Functional Characteristics

Abstract: Background: Arrestin-1 with enhanced binding to unphosphorylated active rhodopsin (Rh*) has therapeutic potential. Results: Manipulation of the rhodopsin binding surface of arrestin-1 greatly increases its binding to Rh*. Conclusion: Stable arrestin-1 with high binding to Rh* can be engineered with and without the ability to self-associate. Significance: The affinity of arrestin-1 for Rh* and its propensity to oligomerize can be independently changed by targeted mutagenesis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
47
0

Year Published

2013
2013
2023
2023

Publication Types

Select...
5
3

Relationship

6
2

Authors

Journals

citations
Cited by 31 publications
(56 citation statements)
references
References 71 publications
(53 reference statements)
4
47
0
Order By: Relevance
“…Sequence entropies were determined using protein interface evaluation with evolutionary analysis (51). facilitate engineering of arrestin-1 with specific functional characteristics (45,46). Transfer of mutations to arrestin-2 and arrestin-3 sets the stage to develop diagnostic and therapeutic tools to study diseases caused by hyperactivity of other GPCRs.…”
Section: Resultsmentioning
confidence: 99%
“…Sequence entropies were determined using protein interface evaluation with evolutionary analysis (51). facilitate engineering of arrestin-1 with specific functional characteristics (45,46). Transfer of mutations to arrestin-2 and arrestin-3 sets the stage to develop diagnostic and therapeutic tools to study diseases caused by hyperactivity of other GPCRs.…”
Section: Resultsmentioning
confidence: 99%
“…Rhodopsin Purification and in Vitro Phosphorylation-Rhodopsin (Rho) in native disk membranes was purified from bovine retina as described previously (26). Opsin was generated from rhodopsin, as described previously (27).…”
Section: Methodsmentioning
confidence: 99%
“…Mutations were introduced by PCR using the strategy previously described (31,32). All constructs were confirmed by dideoxy sequencing.…”
Section: Materials-[␥-mentioning
confidence: 99%
“…Direct binding assay was performed as described (32,33). Briefly, 1 nM arrestin-1 (50 fmol) was incubated with 0.3 g of various functional forms of rhodopsin in 50 l of 50 mM Tris-HCL, pH 7.4, 100 mM potassium acetate, 1 mM EDTA, 1 mM DTT for 5 min at 37°C under room light (P-Rh*, Rh*, or phospho-opsin) or in the dark (P-Rh or Rh).…”
Section: Materials-[␥-mentioning
confidence: 99%
See 1 more Smart Citation